Drug interactions
Dexamethasone-tobramycin + Incobotulinumtoxina
Severity: Moderate
Dexamethasone-tobramycin and Incobotulinumtoxina: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Aminoglycosides such as tobramycin can impair neuromuscular transmission and may potentiate botulinum toxin. This could cause excessive muscle weakness, including swallowing or breathing difficulty, particularly with systemic absorption.
What this interaction means in plain words
Dexamethasone-tobramycin and Incobotulinumtoxina can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive impairment of neuromuscular transmission, with aminoglycosides reducing presynaptic acetylcholine release on top of the toxin's blockade.
What to do
Avoid starting systemic aminoglycoside therapy around the time of botulinum toxin injection when alternatives exist. If both are required, monitor for generalized weakness, dysphagia and respiratory compromise.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-tobramycin and Incobotulinumtoxina, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Frequently asked questions
Can I take Dexamethasone-tobramycin with Incobotulinumtoxina?
MediHelp rates the interaction as moderate. Dexamethasone-tobramycin and Incobotulinumtoxina can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Aminoglycosides such as tobramycin can impair neuromuscular transmission and may potentiate botulinum toxin. This could cause excessive muscle weakness, including swallowing or breathing difficulty, particularly with systemic absorption.
How serious is the interaction between Dexamethasone-tobramycin and Incobotulinumtoxina?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting systemic aminoglycoside therapy around the time of botulinum toxin injection when alternatives exist. If both are required, monitor for generalized weakness, dysphagia and respiratory compromise.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
